RESUMO
The use of electro-convulsive therapy (ECT) in adolescents is controversial, and few studies have been conducted to assess its efficacy and safety in this population. We report the case of a 19-year-old boy who received two series of ECT, one at 15 and another at 16, for intractable catatonic schizophrenia. Since the age of 17, he has required treatment combining clozapine and maintenance ECT. The course showed a sustained moderate improvement. The treatment permitted the patient to regain some autonomy with moderate adverse effects. ECT remains an uncommon treatment in adolescents, and the current case supports the view that it should not be banned in young people.
Assuntos
Eletroconvulsoterapia/métodos , Esquizofrenia Catatônica/terapia , Adolescente , Anestésicos Intravenosos/administração & dosagem , Humanos , Masculino , Transtornos da Memória/diagnóstico , Transtornos da Memória/etiologia , Propofol/administração & dosagem , Esquizofrenia Catatônica/complicações , Esquizofrenia Catatônica/diagnóstico , Índice de Gravidade de Doença , Inquéritos e Questionários , Adulto JovemRESUMO
Anti-NMDA-Receptor encephalitis is a severe form of encephalitis that was recently identified in the context of acute neuropsychiatric presentation. Here, we describe the case of a 17-year-old girl referred for an acute mania with psychotic features and a clinical picture deteriorated to a catatonic state. Positive diagnosis of anti-NMDA-receptor encephalitis suggested specific treatment. She improved after plasma exchange and immunosuppressive therapy. Post-cognitive sequelae (memory impairment) disappeared within 2-year follow-up and intensive cognitive rehabilitation.